Patents/Inventors

Zhiqiang An

Houston, TXUS15 patents

13 Patents

US125961222026
LILRB2 Antibodies and Uses Thereof
IMMUNE-ONC THERAPEUTICS, Inc.
0 cites
US125707102026
Targeting LILRB4 with CAR-T or CAR-NK Cells in the Treatment of Cancer
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites
US125035002025
Connexin 43 (cx43) Hemichannel-binding Antibodies
Board Of Regents, The University Of Texas System
0 cites
US123311102025
Monoclonal Antibodies Against Endotrophin and the Use Thereof
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites
US123311302025
DDR1 Antibodies and Uses Thereof
THE GEORGE WASHINGTON UNIVERSITY
0 cites
US122028952025
LILRB4 Antibodies and Uses Thereof
IMMUNE-ONC THERAPEUTICS, Inc.
0 cites
US121520712024
EGFL6 Specific Monoclonal Antibodies and Methods of Their Use
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites
US120844032024
Linkers for Antibody Drug Conjugates
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites
US120373902024
Leptin Antibodies and Method of Reducing Leptin
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
0 cites
US119127582024
Methods of Treating Metastasis, Including Inhibiting Bone Cancer Metastasis, by Administering an Antibody Which Binds Connexin 43 (cx43) Hemichannel
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites
US119065192024
Methods for Identifying Lilrb-blocking Antibodies
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites
US117607992023
Leptin Antibodies
Board Of Regents, The University Of Texas System
0 cites
US116291222023
Linkers for Antibody Drug Conjugates
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites